logo
Sign InSign Up

CHARLES RIVER LABORATORIES INTERNATIONAL INC (CRL)

Sector: Healthcare

Financial Fundamentals

findl.com provides a comprehensive suite of standardized financial statement data and an assortment of calculated metrics sourced directly from SEC filings, and meticulously cleansed and verified, ensuring reliability. To get the complete financial statement history in quarterly and annual resolution for CRL, sign up here.

Income Statement

Revenue

$4.1bn

Gross Profit

$1.5bn

Earning before Tax

$575.5m

Net Income

$474.6m

Net Income Common Shareholders

$474.6m

EPS

9.27

Balance Sheet

Cash

$276.8m

Debt

$3.1bn

Assets

$8.2bn

Liabilities

$4.5bn

Equity

$3.6bn

Enterprise Value

$14.9bn

Cash Flow Statement

Net Cash from Operations

$683.9m

Net Cash from Investing

$-0.6bn

Net Cash from Financing

$-85.5m

Net Cash Flow

$43.3m

Free Cash Flow

$365.4m

Free Cash Flow per Share

$7.13

Metrics

Price to Equity

25.55

Price to Equity (Damodaran)

25.50

Price to Book

3.37

Net Margin

0.12

Return on Equity

0.14

Return on Sales

0.17

Get immediate access to 5-years of reference grade data for CRL for free.

Sign up

Company Profile

Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company also provides contract vivarium operation services to biopharmaceutical clients. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Company Info

Industry

Diagnostics & Research

Employees

20,000

Address

251 Ballardvale Street
Wilmington, MA 01887
United States

Phone

781 222 6000

Last Updated

2024-02-08

Available Data

Standardized Financial Statements

EOD Price History

Corporate Actions

Institutional Holdings

Insider Transactions

Sign up for free and get immediate access
logo

Radically accessible financial data

Contact Info

findl.com info@findl.com

Explore findl data

DocumentationSupport

Copyright © findl 2024. All rights reserved.

Terms & Use

Privacy Policy